(1) rat anti-mouse B220 (1:100; BD, Franklin Lakes, NJ) and rabbit anti-mouse CD3e (1:100; Invitrogen, Waltham, MA), followed by the secondary antibodies Alexa Fluor 488-conjugated donkey anti-rat and Cy5-conjugated donkey anti-rabbit (both 1:100), respectively;
(2) rabbit anti-mouse syndecan-1 (SDC1) (1:100; Sino Biological, Wayne, PA) and Alexa Fluor 594-conjugated donkey anti-mouse IgG (1:300), followed by the secondary antibodies Alexa Fluor 488-conjugated donkey anti-rabbit (1:100) and Alexa Fluor 594-conjugated donkey anti-mouse IgG (1:500), respectively;
(3) rat anti-human/mouse activation-induced cytidine deaminase (AID) (1:50; Invitrogen, Waltham, MA), followed by biotin-conjugated donkey anti-rat and amplified by the Tyramine Signal Amplification (TSA) Cyanine 5 System from Perkin Elmer (Waltham, MA).
All fluorophore-conjugated antibodies were from Jackson ImmunoResearch (West Grove, PA).